ENTRY       D03669                      Drug
NAME        Deferasirox (JAN/USAN/INN);
            Exjade (TN);
            Jadenu (TN)
PRODUCT     EXJADE (Novartis Pharmaceuticals Corporation)
            JADENU (Novartis Pharmaceuticals Corporation)
  GENERIC   DEFERASIROX (Actavis Pharma)
            DEFERASIROX (Actavis Pharma)
            DEFERASIROX (Alembic Pharmaceuticals Limited)
            DEFERASIROX (Alembic Pharmaceuticals Limited)
            DEFERASIROX (Alembic Pharmaceuticals)
            DEFERASIROX (Alembic Pharmaceuticals)
            DEFERASIROX (Amneal Pharmaceuticals NY LLC)
            DEFERASIROX (Amneal Pharmaceuticals NY LLC)
            DEFERASIROX (Ascend Laboratories)
            DEFERASIROX (Ascend Laboratories)
            DEFERASIROX (Bionpharma)
            DEFERASIROX (Camber Pharmaceuticals)
            DEFERASIROX (Camber Pharmaceuticals)
            DEFERASIROX (Cipla USA)
            DEFERASIROX (Cipla USA)
            DEFERASIROX (Dr. Reddy's Laboratories)
            DEFERASIROX (Dr. Reddy's Laboratories)
            DEFERASIROX (Glenmark Pharmaceuticals)
            DEFERASIROX (MSN LABORATORIES PRIVATE LIMITED)
            DEFERASIROX (MSN LABORATORIES PRIVATE LIMITED)
            DEFERASIROX (Sun Pharmaceutical Industries)
            DEFERASIROX (Sun Pharmaceutical Industries)
            DEFERASIROX (Xiromed)
            DEFERASIROX (Zydus Lifesciences Limited)
            DEFERASIROX (Zydus Lifesciences Limited)
            DEFERASIROX (Zydus Pharmaceuticals USA)
            DEFERASIROX (Zydus Pharmaceuticals USA)
            DEFERASIROX ORAL (Ascend Laboratories)
            DEFERASIROX ORAL GRANULES (EPIC PHARMA)
            DEFERASIROX ORAL GRANULES (OAKRUM PHARMA)
            DEFERASOROX (MSN LABORATORIES PRIVATE LIMITED)
            DEFERASOROX (Novadoz Pharmaceuticals LLC)
FORMULA     C21H15N3O4
EXACT_MASS  373.1063
MOL_WEIGHT  373.3615
CLASS       Vitamin and mineral
             DG01692  Chelator
              DG01691  Iron chelator
            Metabolizing enzyme substrate
             DG02924  UGT substrate
              DG03183  UGT1A1 substrate
              DG03184  UGT1A3 substrate
            Metabolizing enzyme inhibitor
             DG01634  CYP1A2 inhibitor
             DG01641  CYP2C8 inhibitor
            Metabolizing enzyme inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
REMARK      Therapeutic category: 3929
            ATC code: V03AC03
            Product: D03669<JP/US>
EFFICACY    Antidote (iron), Chelating agent
COMMENT     Treatment of iron overload
METABOLISM  Enzyme: UGT1A1 [HSA:54658], UGT1A3 [HSA:54659]
INTERACTION CYP inhibition: CYP1A2 [HSA:1544], CYP2C8 [HSA:1558]
            CYP induction: CYP3A4 [HSA:1576]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V03 ALL OTHER THERAPEUTIC PRODUCTS
               V03A ALL OTHER THERAPEUTIC PRODUCTS
                V03AC Iron chelating agents
                 V03AC03 Deferasirox
                  D03669  Deferasirox (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Electrolytes/Minerals/Metals/Vitamins
              Electrolyte/Mineral/Metal Modifiers
               Deferasirox
                D03669  Deferasirox (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               392  Antidotes
                3929  Others
                 D03669  Deferasirox (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Vitamin and mineral
              DG01692  Chelator
               DG01691  Iron chelator
                D03669  Deferasirox
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               DG03183  UGT1A1 substrate
                D03669  Deferasirox
               DG03184  UGT1A3 substrate
                D03669  Deferasirox
             Metabolizing enzyme inhibitor
              DG01634  CYP1A2 inhibitor
               D03669  Deferasirox
              DG01641  CYP2C8 inhibitor
               D03669  Deferasirox
             Metabolizing enzyme inducer
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                D03669  Deferasirox
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03669
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03669
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03669
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03669
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03669
DBLINKS     CAS: 201530-41-8
            PubChem: 17397765
            ChEBI: 49005
            PDB-CCD: JBL
            LigandBox: D03669
ATOM        28
            1   N5x N     8.9600  -13.9300
            2   C8y C     8.9600  -15.3300
            3   N5x N    10.2915  -15.7626
            4   N4y N    11.1144  -14.6300
            5   C8y C    10.2915  -13.4974
            6   C8y C    12.5144  -14.6300
            7   C8x C    13.2182  -15.8492
            8   C8x C    14.6182  -15.8492
            9   C8y C    15.3183  -14.6368
            10  C8x C    14.6145  -13.4177
            11  C8x C    13.2145  -13.4176
            12  C6a C    16.7300  -14.6370
            13  O6a O    17.4331  -13.4194
            14  O6a O    17.4269  -15.8442
            15  C8y C     7.7476  -16.0300
            16  C8x C     6.5521  -15.3396
            17  C8x C     5.3396  -16.0395
            18  C8x C     5.3394  -17.4395
            19  C8x C     6.5349  -18.1299
            20  C8y C     7.7474  -17.4300
            21  O1a O     8.9766  -18.1400
            22  C8y C    10.2915  -12.0974
            23  C8x C    11.4973  -11.4012
            24  C8x C    11.4974  -10.0012
            25  C8x C    10.2850   -9.3012
            26  C8x C     9.0791   -9.9973
            27  C8y C     9.0791  -11.3973
            28  O1a O     7.8771  -12.0915
BOND        31
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 1
            5     1   5 2
            6     4   6 1
            7     6   7 2
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12    6  11 1
            13    9  12 1
            14   12  13 2
            15   12  14 1
            16    2  15 1
            17   15  16 2
            18   16  17 1
            19   17  18 2
            20   18  19 1
            21   19  20 2
            22   15  20 1
            23   20  21 1
            24    5  22 1
            25   22  23 2
            26   23  24 1
            27   24  25 2
            28   25  26 1
            29   26  27 2
            30   22  27 1
            31   27  28 1
///
